Finance News – Inside Information
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Tariffs
Shares
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Bse
Xrp
Etf
Stablecoin
Investment
Blockchain
Ipo
Eth
Index
Solana
Sec
Trade
Inflation
Earnings
Interest Rates
Revenue
Token
Sensex
Coinbase
Wall Street
Treasury
Nasdaq
Nse
China
Federal Reserve
Traders
Bse Sensex
Nifty
Gold
Sp 500
Tesla
Investor
Profit
Economy
Defi
Framework
Uk Trading Partners
Tariff Terms
Eth Btc
Pick N Pay
Qualification Standards
Dcs
Dfa
Regulatory Path
Price Declines
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jul 10, 2025
EQS-Adhoc: GRAMMER Aktiengesellschaft: Year-on-year change in earnings performance in the second qua...
In the second quarter of 2025, Grammer Aktiengesellschaft reported a notable variation in its profitability compared to the same period last year, reflecting important shifts in it...
Read Full Article →
Business Insider Markets • May 27, 2025
EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
Pentixapharm Holding AG’s updated clinical plan may impact its future investment priorities and resource allocation, potentially influencing the company’s market valuation and shar...
Read Full Article →